Metformin, a widely used ADM, has recently attracted great attention for antitumor effect in a wide range of malignancies including liver cancer, through both insulin-dependent and insulin-independent mechanisms.[4] However, the evidence for a cancer preventive effect for metformin has not been consistently demonstrated. Here, INS is linked to liver cancer.